Highlights on Ocular Toxicity of Immune Checkpoint Inhibitors at a US Tertiary Cancer Center

Highlights on Ocular Toxicity of Immune Checkpoint Inhibitors at a US Tertiary Cancer Center

Introduction: Immune checkpoint inhibitors (ICIs) have improved prognosis in advanced malignancies; however, they may be associated with extensive ocular immune-related adverse events (irAEs) that are sight threatening. Our study aimed to identify the presentation, characteristics, management, and c...

Full description

Bibliographic Details
Main Authors: Anam A. Mazharuddin, Andrew T. Whyte, Dan S. Gombos, Nimisha Patel, Azadeh Razmandi, Amina L. Chaudhry, Nagham S. Al-Zubidi
Format: Article
Language:English
Published: Innovative Healthcare Institute 2022-11-01
Series:Journal of Immunotherapy and Precision Oncology
Subjects:
immune checkpoint inhibitors
ocular immune-related adverse events
nivolumab
ocular toxicity
immunotherapy side effects
Online Access:https://theijpt.org/doi/pdf/10.36401/JIPO-22-14

Internet

https://theijpt.org/doi/pdf/10.36401/JIPO-22-14

Similar Items